Skewed X inactivation and IVF-conceived infants

University of Virginia, Charlottsville, VA 22908, USA.
Reproductive biomedicine online (Impact Factor: 3.02). 02/2010; 20(5):660-3. DOI: 10.1016/j.rbmo.2010.01.011
Source: PubMed


The objective of this study was to investigate whether skewed X chromosome inactivation (XCI) is associated with IVF. A retrospective cohort study was performed comprising 30 female infants conceived by IVF and 44 naturally conceived control infants matched for gestational age and sex. Cord blood DNA samples were obtained and XCI patterns were analysed using a methylation-sensitive assay. Eight IVF samples and 13 control samples were excluded from the study because they were either homozygous or alleles were too similar for the assay to determine skewing. Mildly skewed XCI (80-90% inactivation of one allele) was present in two of 22 (9.1%) IVF samples and two of 31 (6.5%) control samples. Extremely skewed XCI (>90% inactivation of one allele) was found in two of 22 (9.1%) IVF samples and none of 31 control samples. Neither difference was statistically significant. However, the mean degree of skewed XCI in the IVF group was 72.0% and in the control group was 62.4% (P=0.002). Larger studies are needed to clarify the relationship between IVF and skewed XCI.


Available from: Amy E Sparks, Apr 11, 2014
  • Source
    • "This difference indicates that the manipulation of preimplantation embryos influences imprinted gene expression, and this might be the case for human embryos from assisted reproductive technology (ART) treatments as well. Several studies on children conceived with ART treatments have shown a slightly higher incidence in imprinting disorders, an altered sex ratio shifted towards males, altered birth weight and even skewed XCI (Chang et al. 2009; Dumoulin et al. 2010; Halliday et al. 2004; Helmerhorst et al. 2004; King et al. 2010). A number of other reasons may also explain the differences between ART outcome and the general population, such as the reason for infertility of the parents, the ovarian stimulation procedure, the high amount of multiple pregnancies and the extended time to pregnancy (Owen and Segars 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Female eutherians silence one of their X chromosomes to accomplish an equal dose of X-linked gene expression compared with males. The mouse is the most widely used animal model in XCI research and has proven to be of great significance for understanding the complex mechanism of X-linked dosage compensation. Although the basic principles of XCI are similar in mouse and humans, differences exist in the timing of XCI initiation, the genetic elements involved in XCI regulation and the form of XCI in specific tissues. Therefore, the mouse has its limitations as a model to understand early human XCI and analysis of human tissues is required. In this review, we describe these differences with respect to initiation of XCI in human and mouse preimplantation embryos, the extra-embryonic tissues and the in vitro model of the epiblast: the embryonic stem cells.
    Human Genetics 06/2011; 130(2):203-15. DOI:10.1007/s00439-011-1014-9 · 4.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: CO-TPD spectra of CO/Cu(+)/FER system were investigated and analyzed by a combination of experimental and theoretical techniques. Three Cu(+) site types characterized by adsorption energies -122, -76, and -59 kJ/mol were found using a combined quantum mechanical/interatomic potential function method. Three Cu(+) site types with CO adsorption energies -121, -86, and -62 kJ/mol can be distinguished from the analysis of TRD spectra of CO/Cu(+)/FER, TPD spectra call be interpreted in terms of the computational results: CO desorbs first from the Cu(+) sites in the vicinity of two framework AlO(4) tetrahedra, followed by desorption from Cu(+) sites in the perpendicular channel cavity. Sites in the main channel and oil the intersection have the largest desorption energy. Information about the framework aluminum distribution in FER can be also obtained from the analysis of CO-TPD spectra.
    01/2005: pages 925-932; Elsevier Science Bv., ISBN: 0167-2991 0-444-52082-1
  • [Show abstract] [Hide abstract]
    ABSTRACT: DNA methylation deregulation is one of the major components of epigenetic reprogramming affecting many human diseases. Due to its chemical nature and the advances in technology, DNA methylation is unique for biomarker utilization. DNA methylation changes have been detected in a variety of human body fluids associated with a large number of malignant and benign diseases. This chapter summarizes the evidence from a wide range of studies in this field and demonstrates the clinical potential of DNA methylation in cancer diagnostics. The technical approaches are discussed, emphasizing on quality control issues and potential pitfalls. Finally, the lack of transferring this technology to the clinic is being discussed, highlighting key study design issues that are required for biomarker validation and clinical implementation.
    Advances in genetics 01/2010; 71:177-207. DOI:10.1016/B978-0-12-380864-6.00006-7 · 6.76 Impact Factor
Show more